Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

A Call for Evidence-Based Telemetry Monitoring

A Call for Evidence-Based Telemetry Monitoring Letters 5. Leesar MA, Varma J, Shapira A, et al. Prediction of hypertension cant decreases in blood pressure following renal denervation, improvement after stenting of renal artery stenosis: comparative accuracy of but this sham-controlled study identified no such benefit. While translesional pressure gradients, intravascular ultrasound, and angiography. these findings also may be influenced by patient selection, they J Am Coll Cardiol. 2009;53(25):2363-2371. should concern those inclined to recommend interventional 6. Bhatt DL, Kandzari DE, O’Neill WW, et al; SYMPLICITY HTN-3 Investigators. treatment of resistant hypertension presumed due to renovas- A controlled trial of renal denervation for resistant hypertension. N Engl J Med. 2014;370(15):1393-1401. cular causes. Keeping in mind that blood pressure reduction can 7. Esler MD, Krum H, Sobotka PA, Schlaich MP, Schmieder RE, Böhm M; only be considered a surrogate for “hard end points” such as Symplicity HTN-2 Investigators. Renal sympathetic denervation in patients with death, myocardial infarction, stroke, congestive heart failure, treatment-resistant hypertension (the Symplicity HTN-2 Trial): a randomised and renal failure, we seem to be very far removed from any con- controlled trial. Lancet. 2010;376(9756):1903-1909. vincing evidence that renal artery interventions reduce cardio- 8. Krum H, Schlaich M, Whitbourn R, et al. Catheter-based renal sympathetic vascular http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Internal Medicine American Medical Association

A Call for Evidence-Based Telemetry Monitoring

JAMA Internal Medicine , Volume 174 (11) – Nov 1, 2014

Loading next page...
 
/lp/american-medical-association/a-call-for-evidence-based-telemetry-monitoring-Fp6kxfq2DI
Publisher
American Medical Association
Copyright
Copyright 2014 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
2168-6106
eISSN
2168-6114
DOI
10.1001/jamainternmed.2014.3502
pmid
25243346
Publisher site
See Article on Publisher Site

Abstract

Letters 5. Leesar MA, Varma J, Shapira A, et al. Prediction of hypertension cant decreases in blood pressure following renal denervation, improvement after stenting of renal artery stenosis: comparative accuracy of but this sham-controlled study identified no such benefit. While translesional pressure gradients, intravascular ultrasound, and angiography. these findings also may be influenced by patient selection, they J Am Coll Cardiol. 2009;53(25):2363-2371. should concern those inclined to recommend interventional 6. Bhatt DL, Kandzari DE, O’Neill WW, et al; SYMPLICITY HTN-3 Investigators. treatment of resistant hypertension presumed due to renovas- A controlled trial of renal denervation for resistant hypertension. N Engl J Med. 2014;370(15):1393-1401. cular causes. Keeping in mind that blood pressure reduction can 7. Esler MD, Krum H, Sobotka PA, Schlaich MP, Schmieder RE, Böhm M; only be considered a surrogate for “hard end points” such as Symplicity HTN-2 Investigators. Renal sympathetic denervation in patients with death, myocardial infarction, stroke, congestive heart failure, treatment-resistant hypertension (the Symplicity HTN-2 Trial): a randomised and renal failure, we seem to be very far removed from any con- controlled trial. Lancet. 2010;376(9756):1903-1909. vincing evidence that renal artery interventions reduce cardio- 8. Krum H, Schlaich M, Whitbourn R, et al. Catheter-based renal sympathetic vascular

Journal

JAMA Internal MedicineAmerican Medical Association

Published: Nov 1, 2014

References